FibroGen Inc
BMV:FGEN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
FibroGen Inc
BMV:FGEN
|
US |
|
Sun Life Financial Inc
TSX:SLF
|
CA |
|
S
|
Swatch Group AG
XBER:UHR
|
CH |
|
D
|
Dillard's Inc
F:DL7A
|
US |
|
Y
|
Yoc AG
DUS:YOC
|
DE |
|
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
|
US |
|
Alpha Services and Holdings SA
LSE:0RCS
|
GR |
|
F
|
Forte Biosciences Inc
F:37TA
|
US |
|
dotDigital Group PLC
OTC:DOTDF
|
UK |
|
U
|
US Bancorp
F:UB5
|
US |
|
S
|
Stellantis NV
XMUN:8TI
|
NL |
|
A
|
Agricultural Bank of China Ltd
XHAM:EK7
|
CN |
|
D
|
D'Ieteren Group NV
DUS:DJDA
|
BE |
|
C
|
Capital One Financial Corp
F:CFX
|
US |
|
Soditech SA
PAR:ALSEC
|
FR |
|
Swatch Group AG
OTC:SWGAF
|
CH |
|
Avi Ltd
F:IZ6
|
ZA |
|
B
|
Brown-Forman Corp
SWB:BF5B
|
US |
|
Thales SA
PAR:HO
|
FR |
|
M
|
MGIC Investment Corp
BMV:MTG
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is FGEN's stock price target?
Not Available
FGEN does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for FibroGen Inc?
Projected CAGR
-32%
Over the last 11 years, the compound annual growth rate for Revenue has been -11%. The projected CAGR for the next 4 years is -32%.